Literature DB >> 9073509

Analysis of the 5' sequence, genomic structure, and alternative splicing of the presenilin-1 gene (PSEN1) associated with early onset Alzheimer disease.

E I Rogaev1, R Sherrington, C Wu, G Levesque, Y Liang, E A Rogaeva, M Ikeda, K Holman, C Lin, W J Lukiw, P J de Jong, P E Fraser, J M Rommens, P St George-Hyslop.   

Abstract

Mutations in the human presenilin genes (PSEN1 and PSEN2) are associated with early onset familial Alzheimer disease. The presenilin genes encode integral membrane proteins with similar structures, which suggests that they may have closely related, but as yet unknown functions. Analysis of the 5' upstream sequence and the structure of the PSEN1 gene reveals that the 5' sequence contains multiple putative transcription regulatory elements including clusters of STAT elements involved in transcriptional activation in response to signal transduction. The first four exons contain untranslated sequences, with Exons 1 and 2 representing alternate initial transcription sites. The function of these alternate initial exons is unclear. Exon 4 bears the first ATG sequence. The last 12 bp of Exon 4 is used as an alternative splice donor site. Exon 9 is alternately spliced in leukocytes, but not in most other tissues. Splicing of Exon 9 is predicted to cause significant structural changes to the protein. The majority of transcripts expressed in most tissues are polyadenylated 1127 bp from the TAG stop codon in Exon 13. A small proportion of transcripts contain the same 5'UTR and ORF but are polyadenylated 4435 bp from the stop codon. The longer polyadenylated transcripts contain three additional palindromes and at least one additional stem-loop structure with stabilities greater than -16 kcal/mol.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9073509     DOI: 10.1006/geno.1996.4523

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  20 in total

1.  Gene expression profiling in fetal, aged, and Alzheimer hippocampus: a continuum of stress-related signaling.

Authors:  Walter J Lukiw
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

2.  Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer's disease patients.

Authors:  Jessyka Maria de França Bram; Leda Leme Talib; Helena Passarelli Giroud Joaquim; Tamires Alves Sarno; Wagner Farid Gattaz; Orestes Vicente Forlenza
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-05-29       Impact factor: 5.270

Review 3.  Alternative splicing isoforms in health and disease.

Authors:  Hyoung Kyu Kim; Michael Huy Cuong Pham; Kyung Soo Ko; Byoung Doo Rhee; Jin Han
Journal:  Pflugers Arch       Date:  2018-03-13       Impact factor: 3.657

4.  Dissociated phenotypes in presenilin transgenic mice define functionally distinct gamma-secretases.

Authors:  Peter Mastrangelo; Paul M Mathews; M Azhar Chishti; Stephen D Schmidt; Yongjun Gu; Jing Yang; Matthew J Mazzella; Janaky Coomaraswamy; Patrick Horne; Bob Strome; Heather Pelly; Georges Levesque; Chris Ebeling; Ying Jiang; Ralph A Nixon; Richard Rozmahel; Paul E Fraser; Peter St George-Hyslop; George A Carlson; David Westaway
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-10       Impact factor: 11.205

5.  Protein aggregates and novel presenilin gene variants in idiopathic dilated cardiomyopathy.

Authors:  Davide Gianni; Airong Li; Giuseppina Tesco; Kenneth M McKay; John Moore; Kunal Raygor; Marcello Rota; Judith K Gwathmey; G William Dec; Thomas Aretz; Annarosa Leri; Marc J Semigran; Piero Anversa; Thomas E Macgillivray; Rudolph E Tanzi; Federica del Monte
Journal:  Circulation       Date:  2010-03-01       Impact factor: 29.690

6.  Alternative splicing in the N-terminus of Alzheimer's presenilin 1.

Authors:  Wiep Scheper; Rob Zwart; Frank Baas
Journal:  Neurogenetics       Date:  2004-10-05       Impact factor: 2.660

7.  Age-related vascular pathology in transgenic mice expressing presenilin 1-associated familial Alzheimer's disease mutations.

Authors:  Miguel A Gama Sosa; Rita De Gasperi; Anne B Rocher; Athena Ching-Jung Wang; William G M Janssen; Tony Flores; Gissel M Perez; James Schmeidler; Dara L Dickstein; Patrick R Hof; Gregory A Elder
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

8.  Identification and characterization of a new alpha-synuclein isoform and its role in Lewy body diseases.

Authors:  Katrin Beyer; Montserrat Domingo-Sábat; José I Lao; Cristina Carrato; Isidro Ferrer; Aurelio Ariza
Journal:  Neurogenetics       Date:  2007-10-23       Impact factor: 2.660

9.  Sporadic Alzheimer disease fibroblasts display an oxidative stress phenotype.

Authors:  Mahesh Ramamoorthy; Peter Sykora; Morten Scheibye-Knudsen; Christopher Dunn; Cindy Kasmer; Yongqing Zhang; Kevin G Becker; Deborah L Croteau; Vilhelm A Bohr
Journal:  Free Radic Biol Med       Date:  2012-08-03       Impact factor: 7.376

10.  Effects of formalin fixation, paraffin embedding, and time of storage on DNA preservation in brain tissue: a BrainNet Europe study.

Authors:  Isidre Ferrer; Judith Armstrong; Sabina Capellari; Piero Parchi; Thomas Arzberger; Jeanne Bell; Herbert Budka; Thomas Ströbel; Giorgio Giaccone; Giacomina Rossi; Nenad Bogdanovic; Peter Fakai; Andrea Schmitt; Peter Riederers; Safa Al-Sarraj; Rivka Ravid; Hans Kretzschmar
Journal:  Brain Pathol       Date:  2007-04-23       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.